Orchid Pharma

Orchid Pharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orchid Pharma (ORCHPHARMA.NS) as of Nov 6, 2026 is 56.76 M INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 1.45 B INR — a change of -96.08% (lower).

EBITDA

56.76 MINR

YoY

-96.08%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orchid Pharma is 2026 56.76 M INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orchid Pharma was 2025 1.45 B INR. It decreases by -96.08% lower compared to the previous year.

The Orchid Pharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
562.44 M INR
Jan 1, 2020
477.96 M INR
Jan 1, 2021
649.87 M INR
Jan 1, 2022
621.13 M INR
Jan 1, 2023
1.17 B INR
Jan 1, 2024
1.27 B INR
Jan 1, 2025
1.45 B INR
Jan 1, 2026
56.76 M INR
The Orchid Pharma EBITDA history
YEAREBITDAYoY
56.76 MINR-96.08%
1.45 BINR+13.63%
1.27 BINR+9.10%
1.17 BINR+87.85%
621.13 MINR-4.42%
649.87 MINR+35.97%
477.96 MINR-15.02%
562.44 MINR+28.42%
437.95 MINR+37.78%
317.85 MINR-118.06%
-1.76 BINR-155.01%
3.20 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Orchid Pharma Stock analysis

What does Orchid Pharma do? Orchid Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orchid Pharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orchid Pharma is 56.76 M INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Orchid Pharma changed from 1.45 B INR to 56.76 M INR, representing a -96.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Orchid Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Orchid Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Orchid Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Orchid Pharma